Roles of eIF2α kinases in the pathogenesis of Alzheimer's disease

Frontiers in Molecular Neuroscience

Volumn 7, Issue 1 APR, 2014, Pages

  Ohno, Masuo ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid ; ATF4; BACE1; elF2 ; Learning and memory; PERK; PKR

Indexed keywords

INITIATION FACTOR 2; PROTEIN KINASE;

ALZHEIMER DISEASE; APOPTOSIS; GENETIC TRANSCRIPTION; HIPPOCAMPAL CA1 REGION; HUMAN; MEMORY DISORDER; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RECEPTOR UPREGULATION; REVIEW; TRANSLATION INITIATION;

EID: 84898921541     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00022     Document Type: Review

References (59)

1. Abel, T., Martin, K. C., Bartsch, D., and Kandel, E. R. (1998). Memory suppressor genes: inhibitory constraints on the storage of long-term memory. Science 279, 338-341. doi: 10. 1126/science. 279. 5349. 338.
2. Axten, J. M., Medina, J. R., Feng, Y., Shu, A., Romeril, S. P., Grant, S. W., et al. (2012). Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2, 3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2, 3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193-7207. doi: 10. 1021/jm300713s.
3. Azorsa, D. O., Robeson, R. H., Frost, D., Meec hoovet, B., Brautigam, G. R., Dickey, C., et al. (2010). High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation. BMC Genomics 11: 25. doi: 10. 1186/1471-2164-11-25.
4. Baltzis, D., Pluquet, O., Papadakis, A. I., Kazemi, S., Qu, L. K., and Koromilas, A. E. (2007). The eIF2α kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53. J. Biol. Chem. 282, 31675-31687. doi: 10. 1074/jbc. M704491200.
5. Bose, A., Mouton-Liger, F., Paquet, C., Mazot, P., Vigny, M., Gray, F., et al. (2011). Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Brain Pathol. 21, 189-200. doi: 10. 1111/j. 1750-3639. 2010. 00437. x.
6. Cai, Y., Zhang, X. M., Macklin, L. N., Cai, H., Luo, X. G., Oddo, S., et al. (2012). BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology. Neurotox. Res. 21, 160-174. doi: 10. 1007/s12640-011-9256-9.
7. Chang, R. C., Wong, A. K., Ng, H. K., and Hugon, J. (2002). Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13, 2429-2432. doi: 10. 1097/00001756-200212200-00011.
8. Chen, A., Muzzio, I. A., Malleret, G., Bartsch, D., Verbitsky, M., Pavlidis, P., et al. (2003). Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39, 655-669. doi: 10. 1016/S0896-6273(03)00501-4.
9. Chen, Y., Huang, X., Zhang, Y. W., Rockenstein, E., Bu, G., Golde, T. E., et al. (2012). Alzheimer's β-secretase (BACE1) regulates the cAMP/PKA/CREB pathway independently of β-amyloid. J. Neurosci. 32, 11390-11395. doi: 10. 1523/JNEUROSCI. 0757-12. 2012.
10. Costa-Mattioli, M., Gobert, D., Harding, H., Herdy, B., Azzi, M., Bruno, M., et al. (2005). Translational control of hippocampal synaptic plasticity and memory by the eIF2α kinase GCN2. Nature 436, 1166-1173. doi: 10. 1038/nature03897.
11. Costa-Mattioli, M., Gobert, D., Stern, E., Gamache, K., Colina, R., Cuello, C., et al. (2007). eIF2α phosphorylation bidirectionally regulates the switch from short-to long-term synaptic plasticity and memory. Cell 129, 195-206. doi: 10. 1016/j. cell. 2007. 01. 050.
12. Costa-Mattioli, M., and Sonenberg, N. (2008). Translational control of gene expression: a molecular switch for memory storage. Prog. Brain Res. 169, 81-95. doi: 10. 1016/S0079-6123(07)00005-2.
13. Costa-Mattioli, M., Sossin, W. S., Klann, E., and Sonenberg, N. (2009). Translational control of long-lasting synaptic plasticity and memory. Neuron 61, 10-26. doi: 10. 1016/j. neuron. 2008. 10. 055.
14. SLPS1 knock-in mice. J. Biol. Chem. 285, 1272-1282. doi: 10. 1074/jbc. M109. 041954.
15. Couturier, J., Paccalin, M., Lafay-Chebassier, C., Chalon, S., Ingrand, I., Pinguet, J., et al. (2012). Pharmacological inhibition of PKR in APPswePS1dE9 mice transiently prevents inflammation at 12 months of age but increases Aβ42 levels in the late stages of the Alzheimer's disease. Curr. Alzheimer Res. 9, 344-360. doi: 10. 2174/156720512800107582.
16. De Pietri Tonelli, D., Mihailovich, M., Di Cesare, A., Codazzi, F., Grohovaz, F., and Zacchetti, D. (2004). Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic Acids Res. 32, 1808-1817. doi: 10. 1093/nar/gkh348.
17. Devi, L., Alldred, M. J., Ginsberg, S. D., and Ohno, M. (2010). Sex-and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Mol. Brain 3, 34. doi: 10. 1186/1756-6606-3-34.
18. Devi, L., Alldred, M. J., Ginsberg, S. D., and Ohno, M. (2012). Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease. PLoS ONE 7: e32792. doi: 10. 1371/journal. pone. 0032792.
19. Devi, L., and Ohno, M. (2010). Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. PLoS ONE 5: e12974. doi: 10. 1371/journal. pone. 0012974.
20. Devi, L., and Ohno, M. (2013a). Deletion of the eIF2α kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease. PLoS ONE 8: e77335. doi: 10. 1371/journal. pone. 0077335.
21. Devi, L., and Ohno, M. (2013b). Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease. Transl. Psychiatry 3: e284. doi: 10. 1038/tp. 2013. 59.
22. Donnelly, N., Gorman, A. M., Gupta, S., and Samali, A. (2013). The eIF2α kinases: their structures and functions. Cell. Mol. Life Sci. 70, 3493-3511. doi: 10. 1007/s00018-012-1252-6.
23. Endres, K., and Reinhardt, S. (2013). ER-stress in Alzheimer's disease: turning the scale? Am. J. Neurodegener. Dis. 2, 247-265.
24. Erguler, K., Pieri, M., and Deltas, C. (2013). A mathematical model of the unfolded protein stress response reveals the decision mechanism for recovery, adaptation and apoptosis. BMC Syst. Biol. 7: 16. doi: 10. 1186/1752-0509-7-16.
25. Fukumoto, H., Cheung, B. S., Hyman, B. T., and Irizarry, M. C. (2002). β-Secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 1381-1389. doi: 10. 1001/archneur. 59. 9. 1381.
26. Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., et al. (2000). Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108. doi: 10. 1016/S1097-2765(00)00108-8.
27. Ho, Y. S., Yang, X., Lau, J. C., Hung, C. H., Wuwongse, S., Zhang, Q., et al. (2012). Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: implication in Alzheimer's disease pathogenesis. J. Alzheimers Dis. 28, 839-854. doi: 10. 3233/JAD-2011-111037.
28. Holsinger, R. M., McLean, C. A., Beyreuther, K., Masters, C. L., and Evin, G. (2002). Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol. 51, 783-786. doi: 10. 1002/ana. 10208.
29. Hoozemans, J. J., Veerhuis, R., Van Haastert, E. S., Rozemuller, J. M., Baas, F., Eikelenboom, P., et al. (2005). The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 110, 165-172. doi: 10. 1007/s00401-005-1038-0.
30. Ill-Raga, G., Palomer, E., Wozniak, M. A., Ramos-Fernandez, E., Bosch-Morato, M., Tajes, M., et al. (2011). Activation of PKR causes amyloid β-peptide accumulation via de-repression of BACE1 expression. PLoS ONE6: e21456. doi: 10. 1371/journal. pone. 0021456.
31. Jackson, R. J., Hellen, C. U., and Pestova, T. V. (2010). The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113-127. doi: 10. 1038/nrm2838.
32. Jiang, Z., Belforte, J. E., Lu, Y., Yabe, Y., Pickel, J., Smith, C. B., et al. (2010). eIF2α Phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J. Neurosci. 30, 2582-2594. doi: 10. 1523/JNEUROSCI. 3971-09. 2010.
33. Kandalepas, P. C., Sadleir, K. R., Eimer, W. A., Zhao, J., Nicholson, D. A., and Vassar, R. (2013). The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol. 126, 329-352. doi: 10. 1007/s00401-013-1152-3.
34. Kang, E. B., Kwon, I. S., Koo, J. H., Kim, E. J., Kim, C. H., Lee, J., et al. (2013). Treadmill exercise represses neuronal cell death and inflammation during Aβ-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice. Apoptosis 18, 1332-1347. doi: 10. 1007/s10495-013-0884-9.
35. Kim, H. S., Choi, Y., Shin, K. Y., Joo, Y., Lee, Y. K., Jung, S. Y., et al. (2007). Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo. J. Neurosci. Res. 85, 1528-1537. doi: 10. 1002/jnr. 21267.
36. Lammich, S., Schobel, S., Zimmer, A. K., Lichtenthaler, S. F., and Haass, C. (2004). Expression of the Alzheimer protease BACE1 is suppressed via its 5'-untranslated region. EMBO Rep. 5, 620-625. doi: 10. 1038/sj. embor. 7400166.
37. Lee, D. Y., Lee, K. S., Lee, H. J., Kim do, H., Noh, Y. H., Yu, K., et al. (2010). Activation of PERK signaling attenuates Aβ-mediated ER stress. PLoS ONE 5: e10489. doi: 10. 1371/journal. pone. 0010489.
38. Lewerenz, J., and Maher, P. (2009). Basal levels of eIF2α phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 284, 1106-1115. doi: 10. 1074/jbc. M807325200.
39. Li, R., Lindholm, K., Yang, L. B., Yue, X., Citron, M., Yan, R., et al. (2004). Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. U. S. A. 101, 3632-3637. doi: 10. 1073/pnas. 0205689101.
40. Ma, T., Trinh, M. A., Wexler, A. J., Bourbon, C., Gatti, E., Pierre, P., et al. (2013). Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 16, 1299-1305. doi: 10. 1038/nn. 3486.
41. Mihailovich, M., Thermann, R., Grohovaz, F., Hentze, M. W., and Zacchetti, D. (2007). Complex translational regulation of BACE1 involves upstream AUGs and stimulatory elements within the 5' untranslated region. Nucleic Acids Res. 35, 2975-2985. doi: 10. 1093/nar/gkm191.
42. Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., et al. (2013). Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138. doi: 10. 1126/scitranslmed. 3006767.
43. Mouton-Liger, F., Paquet, C., Dumurgier, J., Bouras, C., Pradier, L., Gray, F., et al. (2012). Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Biochim. Biophys. Acta 1822, 885-896. doi: 10. 1016/j. bbadis. 2012. 01. 009.
44. Natunen, T., Parrado, A. R., Helisalmi, S., Pursiheimo, J. P., Sarajarvi, T., Makinen, P., et al. (2013). Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease. J. Alzheimers Dis. 37, 217-232. doi: 10. 3233/JAD-130104.
45. O'Connor, T., Sadleir, K. R., Maus, E., Velliquette, R. A., Zhao, J., Cole, S. L., et al. (2008). Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009. doi: 10. 1016/j. neuron. 2008. 10. 047.
46. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., et al. (2006). Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140. doi: 10. 1523/JNEUROSCI. 1202-06. 2006.
47. Ohno, M., Chang, L., Tseng, W., Oakley, H., Citron, M., Klein, W. L., et al. (2006). Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur. J. Neurosci. 23, 251-260. doi: 10. 1111/j. 1460-9568. 2005. 04551. x.
48. Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., et al. (2007). BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol. Dis. 26, 134-145. doi: 10. 1016/j. nbd. 2006. 12. 008.
49. Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M. C., et al. (2006). Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139, 1343-1354. doi: 10. 1016/j. neuroscience. 2006. 01. 047.
50. Segev, Y., Michaelson, D. M., and Rosenblum, K. (2013). ApoE ε4 is associated with eIF2α phosphorylation and impaired learning in young mice. Neurobiol. Aging 34, 863-872. doi: 10. 1016/j. neurobiolaging. 2012. 06. 020.
51. Silva, A. J., Kogan, J. H., Frankland, P. W., and Kida, S. (1998). CREB and memory. Annu. Rev. Neurosci. 21, 127-148. doi: 10. 1146/annurev. neuro. 21. 1. 127.
52. Stern, E., Chinnakkaruppan, A., David, O., Sonenberg, N., and Rosenblum, K. (2013). Blocking the eIF2α kinase (PKR) enhances positive and negative forms of cortex-dependent taste memory. J. Neurosci. 33, 2517-2525. doi: 10. 1523/JNEUROSCI. 2322-12. 2013.
53. Trinh, M. A., Kaphzan, H., Wek, R. C., Pierre, P., Cavener, D. R., and Klann, E. (2012). Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep. 1, 676-688. doi: 10. 1016/j. celrep. 2012. 04. 010.
54. Vattem, K. M., and Wek, R. C. (2004). Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 101, 11269-11274. doi: 10. 1073/pnas. 0400541101.
55. Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., and Shelanski, M. (2002). Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc. Natl. Acad. Sci. U. S. A. 99, 13217-13221. doi: 10. 1073/pnas. 172504199.
56. Yang, L. B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X. L., et al. (2003). Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3-4. doi: 10. 1038/nm0103-3.
57. Zhang, X.-M., Cai, Y., Xiong, K., Cai, H., Luo, X.-G., Feng, J.-C., et al. (2009). β-Secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Eur. J. Neurosci. 30, 2271-2283. doi: 10. 1111/j. 1460-9568. 2009. 07017. x.
58. Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., et al. (2007). β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci. 27, 3639-3649. doi: 10. 1523/JNEUROSCI. 4396-06. 2007.
59. Zhu, Z., Yan, J., Jiang, W., Yao, X. G., Chen, J., Chen, L., et al. (2013). Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance. J. Neurosci. 33, 13138-13149. doi: 10. 1523/JNEUROSCI. 4790-12. 2013.